Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis
- 1 November 1998
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 352 (9139), 1491-1497
- https://doi.org/10.1016/s0140-6736(98)10039-9
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium)Journal of Neurology, Neurosurgery & Psychiatry, 1998
- Recommendations from the national multiple sclerosis society clinical outcomes assessment task forceAnnals of Neurology, 1997
- Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in PathogenesisBrain Pathology, 1996
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosisThe Lancet, 1991
- A Novel, Quantitative Bioassay for Type I Interferon Using a Recombinant Indicator Cell LineNature Biotechnology, 1990
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979